Yoland Antill is a medical oncologist and specialist in Hereditary Cancer medicine. She has more than 15 years experience in the management of breast and gynaecological cancers. She holds public hospital appointments at Frankston Hospital and Royal Melbourne Hospital together with her private practice at Cabrini Health in Melbourne. She is a lead investigator or co-investigator on multiple national and international studies focused on the management of breast and gynaecological cancers and in hereditary cancer medicine, including the management of urogenital symptoms associated with Breast Cancer treatments.

Caroline Baker is Head of Breast Surgery at St Vincent’s Public Hospital Melbourne, after having serving for 6 years as Director of Breast Services at the Olivia Newton John Cancer and Wellness Centre. She is also Chief Surgeon to St Vincent’s Breast Screen . She gained her FRACS in 1994, then spent 5 years in The UK, subspecialising in the emerging field of breast surgery under the mentorship Mr. Mark Kissin and at The Royal Marsden Hospital in London.
Caroline is a foundation member of BreastSurgANZ, a longterm member of the Australasian Society of Breast Diseases and has been a member of BCT/ANZBCTG since 1998. Caroline regularly teaches students, junior doctors and registrars through The University of Melbourne, lymphoedema practitioners, nurses and volunteers within the Breast Cancer Network of Australia. She has a special interest in neoadjuvant therapy, lymphedema prevention and multidisciplinary care.

Alexandra Barratt (MBBS, MPH, PhD) is an epidemiologist and Professor of Public Health at the University of Sydney. She has participated in a wide range of health services research over the last 25 years, including projects on screening for breast and prostate cancer. Currently, she is a lead investigator of Wiser Healthcare, a research collaboration to reduce overdiagnosis and overtreatment. She is a member of the Scientific Committee for Preventing Overdiagnosis, an international collaboration working to wind back the harms of Too Much Medicine. In 2006 and 2007 she won back-to-back Australian Museum Eureka prizes and is an Australian Museum Eureka Prize Ambassador.

Fran Boyle is a Medical Oncologist at North Sydney’s Mater Hospital, where she is Director of the Patricia Ritchie Centre for Cancer Care and Research, and Professor of Medical Oncology at the University of Sydney. She chairs the Board of the ANZ Breast Cancer Trials Group and has been involved in all facets of clinical trial research in breast cancer.

Dr Alexis Butler has worked as a GP for many years in the UK and Melbourne and is also the GP Liaison Physician at Peter MacCallum Cancer Centre. A core component of her work is improving patient outcomes and experience through optimising collaboration between primary care and hospitals.
Alexis has also worked as a GP education consultant for The Royal Children’s hospital and The Royal Victorian Eye and Ear hospital creating practical face to face, on-line and virtual classrooms programs for primary care. Currently she is also at Victorian Cytology Services involved in research and primary care education on the new national cervical screening program.

Ian Campbell is currently a Consultant Surgeon at Waikato Hospital and an Associate Professor with the Waikato Clinical School, University of Auckland Medical School. He has subspecialised in the management of breast cancer over the last 25 years and has Chaired a number of national committees on breast cancer management and standards of care in NZ, including the NZ Guidelines Group: Management of Early Breast Cancer published by the NZ Ministry of Health in 2009, and the National Breast Cancer Work Group responsible for developing Standards of Service Provision for Breast Cancer, published 2013.
He is very actively involved in clinical research across the spectrum from prevention to better treatment and quality of life. A particular interest is in sentinel node biopsy and management of the axilla, and he is a member of the SNAC Trial Executive and Co-Chair of the SNAC2 Trial. Ian is a long standing member of the ANZ Breast Cancer Trials Group Scientific Advisory Committee, previous Chair of the Local therapy subcommittee, and previous NZ member on the ANZBCTG Board.

Dr. Caudle is an associate professor of breast surgical oncology at the University of Texas MD Anderson Cancer Center. Her research has centered on the surgical management of nodal disease in breast cancer, specifically the development of targeted axillary dissection, a novel surgical technique that improves axillary node staging after neoadjuvant chemotherapy. She also has research interests focusing on improving quality in breast cancer surgery and methods for improving dissemination and implementation of clinical trial data.

Professor Chan graduated from the University of Melbourne, and subsequently obtained her Fellowship in Medical Oncology and a Masters of Medicine in Palliative Care.
She worked in the area of cancer genetics in City Hospital, Nottingham and breast cancer in Princess Margaret Hospital, Toronto. She has worked solely in the area of breast cancer for nearly 20 years and has a strong commitment to breast cancer research, having personally recruited over 1100 patients to clinical trials and has served on the academic steering committee of three international studies. She has authored >100 breast cancer publications in journals including New England Journal of Medicine, Lancet Oncology and Journal of Clinical Oncology; and has been a accessor for UK NHS, young investigator and NHMRC grants.
She is an adjunct professor in the school of medicine at Curtin University and was a founding member of Breast Cancer Research Centre-WA. She established the Helen Sewell Breast Cancer Tumour Bank which has led to the collection of over 3000 annotated breast cancer samples for future research. She is currently the Director of the Breast Clinic Trials Unit of the Breast Cancer Research Centre-WA, based at Hollywood Private Hospital in Perth, Western Australia.
She was awarded the Western Australia of Year Award in Professions 2016 for her contribution in the field of science at a state, national and international level and was a finalist for Australian of the Year in 2017.

Michael Chao is a radiation oncologist specializing in breast and prostate cancers from the University of Melbourne, the Olivia Newton John Cancer and Wellness Centre (ONJCWC) and Genesis Care Victoria (GCV). He is actively involved in both investigator initiated and multicenter studies at the ONJCWC and GVC. His main areas of interest include the use of preoperative radiotherapy in locally advanced breast cancer before definitive mastectomy and autologous breast reconstruction, the use of silicone gels to diminish the incidence of radiation dermatitis in patients undergoing breast/chest wall radiotherapy and the effect of low dose radiation on myocardial function. He is also passionate about the use of high technology such as volumetric arc therapy in breast cancer radiotherapy.

Prof. Louis Chow is Executive Director of the Organization for Oncology and Translational Research in Hong Kong; a distinguished professor of Macau Science Technology; a Medical Director of the Comprehensive Centre for Breast Diseases at the UNIMED Medical Institute in Hong Kong, an honorary professor of the Third Military Medical University; an honorary professor at Ningxia Medical College School of Clinical Medicine in Ningxia, China; an honorary professor at Tohoku University in Sendai, Japan; visiting professor at Wuhan University of Science and Technology; and an honorary consultant of Kiang Wu Hospital in Macau. Professor Chow was the immediate past honorary clinical professor of the clinical trials centre at The University of Hong Kong, past president of the Asian Breast Cancer Society, and former honorary secretary of The Hong Kong Academy of Medicine.
Professor Chow is an expert in cancer research and has obtained a patent on a mouse cell line derived from human malignant cystosarcoma phylloides. In the past few years, he has obtained various research and professional grants for cancer research purposes in the university and contributed as Principal Investigator/Co-investigator of several international clinical trials. Professor Chow has published more than 190 articles in peer-reviewed journals. His key research interests are breast cancer molecular therapy, chemoresistance, chemoprevention and translational research in breast cancer.
Professor Chow was awarded The Kim Hyun-Jib Breast Cancer Research Memorial Award in 2012